SCHEMBL2624191

SCHEMBL2624191

Cc1cc(C)c(N2CN(c3c(C)cc(C)cc3C)c3ccccc3-c3ccccc32)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.38
DNMT1 P26358 1/20 0.36
RAD52 P43351 1/20 0.36
UHRF1 Q96T88 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP2A6 P11509 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CES1 P23141 1/20 0.33
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KCNN4 O15554 2/20 0.32
KCNA3 P22001 2/20 0.32
BRD4 O60885 1/20 0.32
BRD2 P25440 1/20 0.32
BRD3 Q15059 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL919720 0.90 MEN1 (0.38) HTR7KMT2AMEN1CYP1A2CYP2A6
SCHEMBL19259323 0.80 ALDH1A1 (0.36) HTR7KMT2AMEN1CYP1A2CYP2A6
SCHEMBL23894717 0.74 L3MBTL1 (0.37) KMT2AMEN1CYP1A2CYP2A6L3MBTL1
SCHEMBL23186684 0.74 MGLL (0.40) HTR7KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL23186696 0.74 HTR7 (0.38) HTR7KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL820145 0.73 ALDH1A1 (0.35) NPSR1ALDH1A1SMN1; SMN2
SCHEMBL17929854 0.72 KMT2A (0.36) HTR7KMT2AMEN1CYP1A2CYP2A6
Hydrochloric Acid SCHEMBL819271 0.71 ALDH1A1 (0.34) NPSR1ALDH1A1SMN1; SMN2
SCHEMBL760838 0.70 ALDH1A1 (0.33) NPSR1ALDH1A1SMN1; SMN2
SCHEMBL2126293 0.70 ALDH1A1 (0.33) NPSR1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163900-B2 Seven-membered heterocyclic carbenes and their metal complexes WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-04-24 US disclosed
US-20100228024-A1 SEVEN-MEMBERED HETEROCYCLIC CARBENES AND THEIR METAL COMPLEXES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-09-09 US disclosed
US-7750149-B2 Seven-membered heterocyclic carbenes and their metal complexes WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100228024-A1 SEVEN-MEMBERED HETEROCYCLIC CARBENES AND THEIR METAL COMPLEXES CYCS, COG7, SOD1 HTR7 635/4885DNMT1 978/4885RAD52 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.